Mannkind

MNKDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.125 B

$3.50 -1.13%

Close of 21 Sept 2026

Revenue

$349.0M

#2070 by revenue

Earnings

$5.86M

#2157 by earnings

Shares outstanding

321,540,637

Latest filing cover page

P/E ratio

192.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#145Aktis OncologyAKTS$1.19B
#146Seaport TherapeuticsSPTX$1.13B
#147MannkindMNKD$1.13B
#148SavaraSVRA$1.12B
#149ApnimedAPMD$1.09B

What if Mannkind were worth as much as…

Open the what-if tool →

Gold $30.3T

$94,151.99

Per share 26,901× higher

Bitcoin $1.72T

$5,348.57

Per share 1,528× higher

Nvidia $5.48T

$17,042.30

Per share 4,869× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Mannkind are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.